Inventor · disambiguated record
Harald Mauser
Also filed as: MAUSER HARALD
19 granted patents·11 pending applications·65 citations·filing 2006–2020
92Inventor score
Top patents by PatentIndex Score
30 records- 0194US10669268B2Bicyclic derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Jun 2, 2020·9 cites·55 claims
- 0294US10633384B2Diazaspirocycloalkane and azaspirocycloalkaneHOFFMANN LA ROCHE·Filed 2016·Granted Apr 28, 2020·12 cites·12 claims
- 0387US7964594B1Amino oxazine derivativesHOFFMANN LA ROCHE·Filed 2010·Granted Jun 21, 2011·12 cites·30 claims
- 0484US8389513B22-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amidesBANNER DAVID·Filed 2010·Granted Mar 5, 2013·9 cites·31 claims
- 0582US10913745B2Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Feb 9, 2021·3 cites·39 claims
- 0681US7696240B2Fused pyrrole derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Apr 13, 2010·5 cites·20 claims
- 0780US8461160B2DihydropyrimidinonesBANNER DAVID·Filed 2010·Granted Jun 11, 2013·3 cites·20 claims
- 0874US8163793B2Proline derivativesSANCHEZ RUBEN ALVAREZ·Filed 2010·Granted Apr 24, 2012·6 cites·33 claims
- 0973US8815881B21,4,5,6-tetrahydro-pyrimidin-2-ylamine compoundsBANNER DAVID·Filed 2011·Granted Aug 26, 2014·1 cites·14 claims
- 1073US8673894B22,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compoundsBANNER DAVID·Filed 2011·Granted Mar 18, 2014·2 cites·17 claims
- 1168US2020339570A1Bicyclic derivativesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1267US8524710B2Pyrrolidine derivativesBANNER DAVID·Filed 2011·Granted Sep 3, 2013·1 cites·32 claims
- 1366US8748418B21,4-oxazepines as BACE1 and/or BACE2 inhibitorsGABELLIERI EMANUELE·Filed 2012·Granted Jun 10, 2014·2 cites·28 claims
- 1462US2020207769A1Diazaspirocycloalkane and azaspirocycloalkaneHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1560US2014336208A11,4,5,6-tetrahydro-pyrimidin-2-ylamine compoundsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1660US2017050960A1New bicyclic derivativesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1757US2015353559A1New bicyclic derivativesHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1852US2019307737A1Novel piperidine derivativesHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 1952US2013196984A13-amino-5-phenyl-56-dihydro-2h-[1,4]oxazinesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2051US2014045820A12,5,6,7-Tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compoundsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2150US10172843B2Piperidine derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Jan 8, 2019·0 cites·14 claims
- 2250US2015376194A1NEW OCTAHYDRO-PYRROLO[3,4-c]-PYRROLE DERIVATIVES AND ANALOGS THEREOF AS AUTOTAXIN INHIBITORSHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 2348US7705034B2Vinylogous acid derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Apr 27, 2010·0 cites·19 claims
- 2447US2012214806A13-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazinesANDREINI MATTEO·Filed 2012·Application pending·0 cites
- 2546US8188079B23-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazinesANDREINI MATTEO·Filed 2010·Granted May 29, 2012·0 cites·19 claims
- 2646US7612099B2Vinylogous acid derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Nov 3, 2009·0 cites·23 claims
- 2745US8158655B2Sulfonamide derivativesBANNER DAVID·Filed 2008·Granted Apr 17, 2012·0 cites·14 claims
- 2844US2012053200A1Bace 2 inhibitorsMAUSER HARALD·Filed 2011·Application pending·0 cites
- 2936US7893099B2Cyclopentane derivativesHOFFMANN LA ROCHE·Filed 2010·Granted Feb 22, 2011·0 cites·19 claims
- 3035US9242943B21,4 oxazines as BACE1 and/or BACE2 inhibitorsANDREINI MATTEO·Filed 2012·Granted Jan 26, 2016·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Harald Mauser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →